Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity medications compared to lifestyle modification alone. Results indicate that ...

GLP-1RA discontinuation and lack of reinitiation was more common among patients with obesity and without type 2 diabetes than with type 2 diabetes.

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Does ‘Nature’s Ozempic’ exist? Experts say it's complicated. While some supplements could cause a small amount of weight loss ...

People without diabetes can lose up to 13% of their starting weight in 6 months using tirzepatide (Mounjaro) as an off-label ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

Two best friends who took weight loss drugs to lose the extra weight had very different experiences, and now, they've spoken ...

We recently published a list of 12 Best Quality Stocks to Invest in Now. In this article, we are going to take a look at ...